Literature DB >> 11445251

Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.

A Dranovsky1, I Vincent, L Gregori, A Schwarzman, D Colflesh, J Enghild, W Strittmatter, P Davies, D Goldgaber.   

Abstract

Nucleolin is a major multifunctional nuclear phosphoprotein that is phosphorylated by Cdc2 kinase in mitosis and that participates in a number of cellular processes. The monoclonal antibody TG-3 generated against neurofibrillary tangles (NFT) found in Alzheimer's disease (AD) is highly specific for mitotic cells in culture. We here demonstrate that phosphorylation of nucleolin by Cdc2 kinase generates the TG-3 epitope. The unique pool of TG-3 immunoreactive nucleolin appears abruptly during the prophase. It is associated with chromosomes through the metaphase and it gradually disappears during separation of chromosomes and exit from mitosis. In the brain, nucleolin was localized not only to nuclei but also to neuronal cytoplasm, and it is a marker for early NFT. In patients with AD, Cdc2 phosphorylated nucleolin was present in NFT. These findings suggest that phosphorylation of nucleolin by Cdc2 kinase is a critical event and the point of convergence of two distinct pathways, mitosis and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445251     DOI: 10.1016/s0197-4580(00)00248-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

1.  A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability.

Authors:  Dongyun Zhang; Yuguang Liang; Qipeng Xie; Guangxun Gao; Jinlong Wei; Haishan Huang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 2.  RNA-binding protein nucleolin in disease.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  RNA Biol       Date:  2012-05-23       Impact factor: 4.652

3.  Effects of suppressed autophagy on mitochondrial dynamics and cell cycle of N2a cells.

Authors:  Meng-Cui Gui; Bo Chen; Shan-Shan Yu; Bi-Tao Bu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

4.  Competitive regulation of nucleolin expression by HuR and miR-494.

Authors:  Kumiko Tominaga; Subramanya Srikantan; Eun Kyung Lee; Sarah S Subaran; Jennifer L Martindale; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2011-08-22       Impact factor: 4.272

5.  Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.

Authors:  Min Zhang; Jin Li; Paramita Chakrabarty; Bitao Bu; Inez Vincent
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 6.  The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease.

Authors:  Antonio Currais; Tibor Hortobágyi; Salvador Soriano
Journal:  Aging (Albany NY)       Date:  2009-04-28       Impact factor: 5.682

7.  A role for a novel protein, nucleolin, in Parkinson's disease.

Authors:  W Michael Caudle; Efstathia Kitsou; Jane Li; Joshua Bradner; Jing Zhang
Journal:  Neurosci Lett       Date:  2009-05-04       Impact factor: 3.046

8.  The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.

Authors:  Dongyun Zhang; Jingxia Li; Min Zhang; Guangxun Gao; Zhenghong Zuo; Yonghui Yu; Linda Zhu; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

9.  Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.

Authors:  Wen-Lin An; Richard F Cowburn; Lin Li; Heiko Braak; Irina Alafuzoff; Khalid Iqbal; Inge-Grundke Iqbal; Bengt Winblad; Jin-Jing Pei
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit.

Authors:  Tamara A Potapova; John R Daum; Kendra S Byrd; Gary J Gorbsky
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.